These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3523892)

  • 1. Prolongation of canine cardiac allograft survival using donor-specific buffy coat pretransfusions.
    Kurlansky PA; Dresdale AR; Pierson R; McManus RP; Michler RE; Sachs H; Thomas WG; Lau H; Hardy MA; Marboe C
    Transplantation; 1986 Jul; 42(1):98-101. PubMed ID: 3523892
    [No Abstract]   [Full Text] [Related]  

  • 2. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
    Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
    Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ultraviolet-B-irradiated donor-specific blood transfusion and cyclosporine on cardiac allograft survival and mixed lymphocyte reaction in rats.
    Koh YB; Park IY; Lee YK
    Transplant Proc; 1994 Aug; 26(4):1952-3. PubMed ID: 8066632
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged allograft survival following cell transfusions.
    Baldwin WM; Null WL; Tilney NL
    Surg Forum; 1977; 28():334-5. PubMed ID: 364727
    [No Abstract]   [Full Text] [Related]  

  • 5. Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion.
    Okazaki H; Takahashi H; Miura K; Ishizaki M; Taguchi Y
    Transplantation; 1984 May; 37(5):523-5. PubMed ID: 6233767
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of rat cardiac allograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Jin YT; Lee PH; Lee CJ
    Transplant Proc; 1994 Aug; 26(4):2323-6. PubMed ID: 8066761
    [No Abstract]   [Full Text] [Related]  

  • 7. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion of blood components and skin allograft survival in rabbits.
    Fagiolo U; Corsano A; Zanon GF; Zannini G; Sogaro F; Lise M
    Transplant Proc; 1979 Jun; 11(2):1446-7. PubMed ID: 382537
    [No Abstract]   [Full Text] [Related]  

  • 9. Transplant outcome with donor specific buffy-coat and lymphocyte-transfused patients.
    Okazaki H; Takahashi H; Jimbo M; Iguro T; Satoh T; Ishizak M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1832-3. PubMed ID: 2652595
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.
    Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ
    Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressor cell induction in donor-specific transfused mouse heart recipients.
    Shelby J; Wakely E; Corry RJ
    Surgery; 1984 Aug; 96(2):296-301. PubMed ID: 6235611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious tolerance mediated by CD8+ T-suppresor cells after UV-B-irradiated donor-specific transfusion and rat heart transplantation.
    Witkowski P; Liu JW; Jin MX; Liu Z; Suciu-Foca N; Hardy MA
    Transplant Proc; 2005; 37(1):43-5. PubMed ID: 15808541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ultraviolet B-irradiated donor leukocytes and peritransplant cyclosporine on cardiac allograft survival in presensitized rats.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):867-70. PubMed ID: 2815259
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of blood transfusions on antibody formation and canine renal allograft survival.
    Currier CB; Pierce JC
    Surg Gynecol Obstet; 1974 Aug; 139(2):241-4. PubMed ID: 4601702
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
    Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
    Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S; Nakafusa Y; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of azathioprine and steroids to augment one-day-pretransplant donor-specific transfusion-enhanced allograft survival.
    Madden RL; Brunson ME; Alexander JW; Davies CB
    Transplantation; 1993 Jun; 55(6):1436-8. PubMed ID: 8516833
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of blood transfusion and cyclophosphamide on cardiac allograft survival in sensitized mice.
    Lasek W; Sora M; Jakóbisiak M
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):399-403. PubMed ID: 8572899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.